Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Trade Name||Synonyms||Drug Classes||Drug Description|
|FL-101||FL 101|FL101|Anti-IL-1 Beta Monoclonal Antibody FL-101||FL-101 is a monoclonal antibody that targets interleukin-1 beta (IL-1b) and blocks its binding to the IL-1 receptor, potentially resulting in decreased IL-1b downstream signaling and inflammatory response, and inhibition of tumorigenesis and angiogenesis (NCI Drug Dictionary).|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status||Covered Countries||Other Countries|
|NCT04758949||Phase II||Nivolumab FL-101 + Nivolumab FL-101||FL-101 in Surgically Resectable Non-Small Cell Lung Cancer||Recruiting||USA | CAN||2|